Please complete the CAPTCHA to continue
@cirisenergy.com
✓
3 phones found area 919
✓
LinkedIn matched
A concise factual answer block for searchers comparing this professional profile.
Joel Sevinsky is listed as Founder and CEO at Theiagen Genomics at Theiagen Genomics, based in Denver Metropolitan Area, United States, United States. AeroLeads shows a work email signal at cirisenergy.com, phone signal with area code 919, and a matched LinkedIn profile for Joel Sevinsky.
Joel Sevinsky previously worked as Founder and CEO at Theiagen Genomics and Head of Molecular Science Laboratory at Colorado Department Of Public Health And Environment. Joel Sevinsky holds Ph.D., Molecular, Cellular, And Developmental Biology from University Of Colorado Boulder.
This section adds company-level context without repeating Joel Sevinsky's masked contact details.
AeroLeads found 1 current-domain work email signal for Joel Sevinsky. Compare company email patterns before reaching out.
Scientific leader for public health bioinformatics, genomics, and molecular biology. Strong focus on improving outbreak surveillance and detection using distributed cloud-based bioinformatics and NGS, especially as it applies to food safety. Frequent speaker and trainer at both national and regional public health/infectious disease conferences.
Listed skills include Molecular Biology, Microbiology, Bioinformatics, Genomics, and 35 others.
Company context helps verify the profile and gives searchers a useful next step.
A career timeline built from the work history available for this profile.
Highlands Ranch, CO, US
Primary focus is the innovative implementation of bioinformatics resources for infectious disease surveillance. Specialize in the utilization of cloud computing resources for on demand, inexpensive, scalable bioinformatic solutions.
Designed and developed the CDPHE Advanced Molecular Detection (AMD) platform for outbreak surveillance and detection. Platform consists of pathogen characterization using next generation sequencing (NGS) and distributed cloud-based bioinformatics analysis. Sequencing and analysis occur in real-time for quick and effective public health response to pathogen.
Directed the Molecular and Microbiology Program responsible for developing novel microorganisms for the bioconversion of biomass derived sugars into valuable biochemicals traditionally produced by the petroleum industry. This program included genetic and metabolic engineering to develop microorganisms producing dicarboxylic acids, enzyme hydrolysis for the.
Lead a multidisciplinary team of scientists improving the rate and yield of biogenic methane production from subsurface hydrocarbon deposits. Areas of responsibility include 1) understanding the nature and function of indigenous microbes in subsurface hydrocarbon deposits, 2) understanding the bioavailable hydrocarbon resource utilized by these microbes.
A leader in the development and execution of our Intellectual Property Strategy aimed at protecting Luca’s proprietary technology both in the US and internationally.One of several team members directing the actions of a multidisciplinary team of microbiologists, molecular biologists, geologists, reservoir engineers, and field operators with regards to.
Research Triangle Park, NC, US
Created bioinformatics tools for whole genome searching using shotgun proteomic data for identification of novel open reading frames. Developed methods to apply this technology to microbial genome annotation using metagenomic sequences from mixed microbial communities. Tools also employed for the detection of novel SNPs in human clinical samples.Developed.
Boulder, Colorado, US
Integrated proteomic and genomic data sets to examine changes in mRNA and protein simultaneously during activation of the MAPK pathway during human megakaryocyte differentiation.Analyzed the transcriptional program of megakaryocyte differentiation in human peripheral blood CD34+ stem cells and K562 erythroleukemia cells using Affymetrix microarrays.Studied.
Boulder, Colorado, US
Integrated proteomic and genomic data sets to examine changes in mRNA and protein simultaneously during activation of the MAPK pathway during human megakaryocyte differentiation.Analyzed the transcriptional program of megakaryocyte differentiation in human peripheral blood CD34+ stem cells and K562 erythroleukemia cells using Affymetrix microarrays.Studied.
La Jolla, California, US
Discovered role of caveolae in regulating ligand-induced cell surface proteolysis of the tissue factor-dependent coagulation pathway.Research led to novel insights on how tissue factor, factor VII, factor X, and TFPI interact on the endothelial cell surface, sequester into caveolae, and regulate the tissue factor-dependent coagulation pathway.
Quick answers generated from the profile data available on this page.
Joel Sevinsky works for Theiagen Genomics.
Joel Sevinsky is listed as Founder and CEO at Theiagen Genomics at Theiagen Genomics.
AeroLeads has found 1 work email signal at @cirisenergy.com for Joel Sevinsky at Theiagen Genomics.
AeroLeads has found 3 phone signal(s) with area code 919 for Joel Sevinsky at Theiagen Genomics.
Joel Sevinsky is based in Denver Metropolitan Area, United States, United States while working with Theiagen Genomics.
Joel Sevinsky has worked for Theiagen Genomics, Colorado Department Of Public Health And Environment, Ciris Energy, Inc, Luca Technologies, and Research Triangle Institute.
You can use AeroLeads to view verified contact signals for Joel Sevinsky at Theiagen Genomics, including work email, phone, and LinkedIn data when available.
Joel Sevinsky holds Ph.D., Molecular, Cellular, And Developmental Biology from University Of Colorado Boulder.
Joel Sevinsky is listed with skills including Molecular Biology, Microbiology, Bioinformatics, Genomics, Cell, Biochemistry, Proteomics, and Biotechnology.
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial Search contacts